Riskpilot← Back to searchSign inGet full accessInjecto Group A/S
A/SActiveCVR 35806555Strandvejen 60Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20141 employeeswww.injecto.eu
Revenue 2024
DKK 343K
+243% vs 2023
EBITDA margin
-1175.5%
+8% vs 2023
Equity ratio
98.3%
Financial strength
Net profit 2024
DKK -6,5M
+8% vs 2023
| Revenue | DKK 343K | +243% |
| EBITDA | DKK -4M | +8% |
| Net profit | DKK -6,5M | +8% |
| Total assets | DKK 55,9M | -2% |
| Equity | DKK 55M | -1% |
| Employees | 1 | — |
Legal name
Injecto Group A/S
CVR number
35806555
Legal form
Aktieselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
16. marts 2014
Share capital
DKK 123.460.180
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-08-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør og 2 bestyrelsesmedlemmer i forening, den samlede
bestyrelse eller af den administrerende direktør og bestyrelsesformanden i
forening.
Company purpose
Selskabets formål er at drive virksomhed med udvikling, markedsføring og distribution af medicinske redskaber og dermed efter bestyrelsens opfattelse beslægtet virksomhed.
Address
Strandvejen 60
Phone
+4527851000
Email
info@injecto.eu
Website
www.injecto.eu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -2.440 | 567 | 100 | 100 | 100 | 100 | 707 | 136 | 100 | 343 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -3.548 | -2.575 | -2.772 | -4.786 | -4.118 | -2.841 | -5.026 | -5.088 | -4.408 | -4.035 |
| Depreciation & amort. | -21 | -72 | -171 | -404 | -298 | -2.441 | -2.998 | -2.760 | -2.882 | -3.048 |
| EBIT | -3.569 | -2.647 | -2.943 | -5.190 | -4.416 | -5.282 | -8.024 | -7.848 | -7.290 | -7.083 |
| Net financials | -41 | -0 | -9 | -29 | 17 | -2.845 | -1.433 | -6.095 | 153 | 536 |
| Profit before tax | -3.610 | -2.665 | -2.952 | -5.219 | -4.399 | -8.128 | -9.457 | -13.943 | -7.137 | -6.547 |
| Tax | -758 | -589 | -639 | -0 | -0 | 695 | -0 | 1.291 | -0 | -0 |
| Net profit | -2.852 | -2.075 | -2.313 | -5.219 | -4.399 | -8.823 | -9.457 | -15.234 | -7.137 | -6.547 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 9.016 | 6.583 | 7.242 | 10.060 | 10.774 | 47.035 | 46.088 | 40.083 | 57.133 | 55.904 |
| Equity | 8.120 | 6.030 | 5.263 | 7.442 | 3.196 | 28.982 | 25.403 | 38.458 | 55.466 | 54.970 |
| Long-term debt | 0 | 0 | 0 | 500 | 450 | 0 | 19.404 | 150 | 130 | 0 |
| Short-term debt | 897 | 553 | 1.979 | 2.118 | 7.128 | 1.002 | 1.281 | 1.474 | 1.537 | 933 |
| Total debt | 897 | 553 | 1.979 | 2.618 | 7.578 | 18.053 | 20.685 | 1.624 | 1.668 | 933 |
EBITDA margin
-1175.5%
This company
15.8%
Market median
-7540% vs market
20152024
Equity ratio
98.3%
This company
38.2%
Market median
+157% vs market
20152024
Return on equity
-11.9%
This company
18.4%
Market median
-165% vs market
20152024
Net profit margin
-1907.4%
This company
8.1%
Market median
-23648% vs market
20152024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20152024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20152024
- Annual report 2024Filed via CVR / Virk · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via CVR / Virk · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via CVR / Virk · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via CVR / Virk · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via CVR / Virk · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via CVR / Virk · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via CVR / Virk · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via CVR / Virk · Period 2016-09-01 – 2017-08-31
- Annual report 2016Filed via CVR / Virk · Period 2015-09-01 – 2016-08-31
- Annual report 2015Filed via CVR / Virk · Period 2014-03-16 – 2015-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TH Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
MH Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Chairman | 2014 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2014 | — | — | |
| Chairman | 2014 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20.0% | 20.0% | 2026 | |
Tina Hetting Holding I ApS | Company | 10.0% | 10.0% | 2023 |
Tina Hetting Holding II ApS | Company | 5.0% | 5.0% | 2023 |
| Individual | 5.0% | 5.0% | 2024 | |
SPRØJTEFABRIKKEN ApS | Company | 5.0% | 5.0% | 2026 |
AC Management ApS | Company | 5.0% | 0.0% | 2019 |
Selskabet af 1. juni 2005 A/S | Company | 15.0% | 15.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DOPEN HOLDING ApS
Injecto Group A/S Board members of Injecto Group A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Torben Helmer Knudsen | Chief Executive Officer | 0 companies |
| Mikael Hans Andranik Hetting | Chief Executive Officer | 0 companies |
| Claudia Hauke | Board of Directors | 0 companies |
| Tina Hetting | Chairman | 0 companies |
| Torben Steen Jensen | Board of Directors | 0 companies |
| Emil Bue Bredel | Board of Directors | 0 companies |
| Henrik Lawaetz | Board of Directors | 0 companies |
| Thomas Sonne-Schmidt | Board of Directors | 0 companies |
| Marie Foegh | Chairman | 0 companies |
| Carsten Sylvester Larsen | Board of Directors | 0 companies |